Market Overview:
The global percutaneous transluminal coronary angioplasty (PTCA) catheters market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in PTCA catheters, and rising demand for minimally invasive procedures. Based on type, the global PTCA catheters market is segmented into 6mm length, 10mm length, 15mm length, 20mm length and others. The 10 mm length segment is expected to account for the largest share of the global PTCA catheters market in 2018. This segment is also projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. This growth can be attributed to its high adoption rate due to its low profile and easy maneuverability characteristics as compared with other types of PTCA catheters available in the market. Based on application, hospitals are expected account for majority share of revenue generated by sales of PTCA Catheters globally by 2020 owing higher number treatments done annually as compared clinics which offer outpatient services across regions such North America & Europe where reimbursement scenario favors hospital setting treatment over clinic visits .
 Catheters Industry Outlook.svg)
Product Definition:
A percutaneous transluminal coronary angioplasty (PTCA) catheter is a long, thin tube that is inserted through a vein in the arm and passed through to the heart. Once in place, it can be used to inflate a tiny balloon at the end of the catheter. This balloon is then used to push open narrowed or blocked arteries supplying blood to the heart muscle.
6mm Length:
6mm length is the standard length of a coronary angioplasty catheter. It has been used as a standard gauge for more than 15 years and its use does not seem to be decreasing any time soon. The 6 mm PTCA catheters are longer than 5 mm but shorter than 8 mm, which is the average size of an angioplasty stent, thus they are most commonly used in patients with coronary artery disease.
10mm Length:
The 10mm length catheters are used in PTCA (Percutaneous Transluminal Coronary Angioplasty) to clear blocked coronary arteries. The 10 mm length catheter is inserted into the artery and inflated with radiofrequency energy to clear the blockage. This procedure is performed by a cardiac interventionalist or cardiologist under local anesthesia.
Application Insights:
Based on application, the global percutaneous transluminal coronary angioplasty catheters market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of cardiovascular diseases and rising number of patients undergoing PTCA procedures. Moreover, increasing government funding for cardiac care and initiatives to improve access to PTCA are further expected to drive growth over the forecast period.
The clinic segment is anticipated register significant growth during the forecast period owing to growing awareness about heart disease coupled with an increase in patient acceptance for invasive treatment options such as percutaneous transluminal coronary angioplasty (PTCA). Increasing availability of advanced diagnostic equipment along with rising income levels has led many people from low-income countries seek medical advice regarding their chests pain or discomfort which eventually leads them towards a cardiologist for proper diagnosis & treatment.
Regional Analysis:
North America dominated the global percutaneous transluminal coronary angioplasty catheters market in 2017. This can be attributed to the high adoption of advanced technologies, availability of skilled physicians, and favorable reimbursement policies. The U.S.
In addition to this, growing awareness among people about PTCA treatments is also expected to boost demand for percutaneous transluminal coronary angioplasty devices in North America over the forecast period. Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing geriatric population base that requires medical attention on a prioritybasis along with rising disposable income levels that enable people access better treatment options than before.
Growth Factors:
- Technological advancements in PTCA catheters that can help improve the accuracy and safety of the procedure.
- Increasing incidence of coronary artery diseases (CAD) due to changing lifestyles and aging population.
- Growing demand for minimally invasive procedures for treatment of CADs.
- Rising healthcare expenditure and increasing awareness about PTCA among patients and physicians alike.
Scope Of The Report
Report Attributes
Report Details
Report Title
Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Research Report
By Type
6mm Length, 10mm Length, 15mm Length, 20mm Length, Others
By Application
Hospital, Clinic, Others
By Companies
Medtronic, Boston Scientific, Abbott, Pressure Products, Inc, B. Braun, ALVIMEDICA, Balton, Biosensors, Biotronik, Endocor, HEXACATH, Natec Medical, SIS Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Report Segments:
The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters market is segmented on the basis of:
Types
6mm Length, 10mm Length, 15mm Length, 20mm Length, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Abbott
- Pressure Products, Inc
- B. Braun
- ALVIMEDICA
- Balton
- Biosensors
- Biotronik
- Endocor
- HEXACATH
- Natec Medical
- SIS Medical
 Catheters Market Overview.svg)
Highlights of The Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 6mm Length
- 10mm Length
- 15mm Length
- 20mm Length
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Catheters Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A percutaneous transluminal coronary angioplasty (PTCA) catheter is a long, thin tube that is inserted through the side of your chest into your heart. The catheter is then threaded through an opening in your heart and into the arteries that supply blood to it. A balloon is then attached to the end of the catheter and inflated, using air or gas, to open up blocked arteries.
Some of the major players in the percutaneous transluminal coronary angioplasty (ptca) catheters market are Medtronic, Boston Scientific, Abbott, Pressure Products, Inc, B. Braun, ALVIMEDICA, Balton, Biosensors, Biotronik, Endocor, HEXACATH, Natec Medical, SIS Medical.
The percutaneous transluminal coronary angioplasty (ptca) catheters market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market - Supply Chain
4.5. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Forecast
4.5.1. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size (000 Units) and Y-o-Y Growth
4.5.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Absolute $ Opportunity
5. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Type
5.3.1. 6mm Length
5.3.2. 10mm Length
5.3.3. 15mm Length
5.3.4. 20mm Length
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Demand Share Forecast, 2019-2026
9. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Type
9.7.1. 6mm Length
9.7.2. 10mm Length
9.7.3. 15mm Length
9.7.4. 20mm Length
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Demand Share Forecast, 2019-2026
10. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Type
10.7.1. 6mm Length
10.7.2. 10mm Length
10.7.3. 15mm Length
10.7.4. 20mm Length
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Demand Share Forecast, 2019-2026
11. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Type
11.7.1. 6mm Length
11.7.2. 10mm Length
11.7.3. 15mm Length
11.7.4. 20mm Length
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Demand Share, 2019-2026
12. Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Type
12.7.1. 6mm Length
12.7.2. 10mm Length
12.7.3. 15mm Length
12.7.4. 20mm Length
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Demand Share, 2019-2026
13. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market Size and Volume Forecast by Type
13.7.1. 6mm Length
13.7.2. 10mm Length
13.7.3. 15mm Length
13.7.4. 20mm Length
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market: Market Share Analysis
14.2. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Distributors and Customers
14.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pressure Products, Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. B. Braun
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ALVIMEDICA
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Balton
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biosensors
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biotronik
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Endocor
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. HEXACATH
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Natec Medical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. SIS Medical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
